Contraception use and HIV outcomes among women initiating dolutegravir-containing antiretroviral therapy in Kenya: a retrospective cohort study.
John M HumphreyVictor OmodiCaitlin BernardMercy MainaJulie ThorneAnn MwangiKara Wools-KaloustianRena C PatelPublished in: Journal of the International AIDS Society (2022)
Baseline, but not incident, effective contraception use was higher during the interim guideline period compared to before it, suggesting women already using effective contraception were preferentially selected to initiate DTG after the guideline was released. These findings reveal challenges in the implementation of policy which ties antiretroviral access to contraceptive use. Future guidance should capture nuances of contraception decision-making and support women's agency to make informed decisions.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- polycystic ovary syndrome
- hiv aids
- hiv infected patients
- pregnancy outcomes
- decision making
- healthcare
- primary care
- cervical cancer screening
- mental health
- breast cancer risk
- men who have sex with men
- type diabetes
- hiv testing
- south africa
- quality improvement
- single cell
- gene expression
- current status
- pregnant women